Phase one trials can exploit terminally ill patients.
D003071:Cognition; D032882:Comprehension; D030881:Disclosure; D064420:Drug-Related Side Effects and Adverse Reactions; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D009369:Neoplasms; D033281:Nontherapeutic Human Experimentation; D004364:Pharmaceutical Preparations; D010820:Physicians; D012108:Research Personnel; D035842:Research Subjects; D019452:Terminally Ill; D014481:United States
Biomedical and Behavioral Research